Mette Reilev

Medicine & Life Sciences

1. Adrenal Cortex Hormones 39%
2. Amoxicillin 16%
3. Angiotensin Receptor Antagonists 44%
4. Angiotensin-Converting Enzyme Inhibitors 28%
5. Anti-Bacterial Agents 16%
6. Anti-Inflammatory Agents 32%
7. Bronchodilator Agents 28%
8. Budesonide 28%
9. Calcium Channel Blockers 20%
10. Case-Control Studies 21%
11. Child 19%
12. Chronic Obstructive Pulmonary Disease 60%
13. Chronic Urticaria 29%
14. Cohort Studies 47%
15. Comorbidity 14%
16. Coronavirus 83%
17. Databases 16%
18. Denmark 72%
19. Drug Utilization 100%
20. Epidemiology 17%
21. Health 19%
22. Histamine Antagonists 25%
23. Hospitalization 34%
24. Human Influenza 40%
25. Information Storage and Retrieval 23%
26. Intensive Care Units 31%
27. Lactulose 29%
28. Microscopic Colitis 34%
29. Morbidity 26%
30. Mortality 37%
31. Multimorbidity 33%
32. Non-Steroidal Anti-Inflammatory Agents 20%
33. Nursing Homes 45%
34. Odds Ratio 69%
35. Omalizumab 31%
36. Osteoporotic Fractures 26%
37. Penicillin V 14%
38. Pharmaceutical Preparations 39%
39. Pneumonia 19%
40. Polymerase Chain Reaction 22%
41. Population 36%
42. Prescription Drugs 36%
43. Prescriptions 60%
44. Proton Pump Inhibitors 27%
45. Registries 37%
46. Renin-Angiotensin System 22%
47. SARS Virus 32%
48. Scandinavian and Nordic Countries 31%
49. Severe Acute Respiratory Syndrome 85%
50. Therapeutics 21%